Prevalence of oxa-type β-lactamases among Acinetobacter baumannii isolates from northwest of Iran

Microbial Drug Resistance

Volumn 18, Issue 4, 2012, Pages 385-389

  Sohrabi, Nasrollah ^a,b   Farajnia, Safar ^c,d   Akhi, Mohammad Taghi ^b   Nahaei, Mohammad Reza ^b   Naghili, Behrooz ^a   Peymani, Amir ^e   Amiri, Zohreh ^f   Rezaee, Mohammad Ahangarzadeh ^b   Saeedi, Nazli ^d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f RAZI UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; BACTERIAL DNA; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLAVULANIC ACID; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULBACTAM; TICARCILLIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; GROWTH INHIBITION; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; IRAN; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; DNA TRANSPOSABLE ELEMENTS; FEMALE; GENES, BACTERIAL; HUMANS; IRAN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PLASMIDS; POLYMERASE CHAIN REACTION;

ACINETOBACTER BAUMANNII;

EID: 84864369677     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2011.0077     Document Type: Article

References (32)

1. Bergogne-Bérézin, E., and K.J. Towner. 1993. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165.
2. Bou, G., A. Oliver, and J. Martinez-Beltran. 2000. OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob. Agents Chemother. 44:1556-1561.
3. Clinical and Laboratory Standard Institute (CLSI). 2006. Performance standards for antimicrobial susceptibility testing: 16th Informational Supplement Document M100-S16. CLSI, Wayne, PA.
4. Corvec, S., N. Caroff, and E. Espaze. 2003. AmpC hyperproduction in Acinetobacter baumannii clinical isolates. J. Antimicrob. Chemother. 52:629-635.
5. Corvec, S., L. Poirel, T. Naas, H. Drugeon, and P. Nordmann. 2007. Genetics and expression of the carbapenemhydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:1530-1533.
6. Donald, H.M., W. Scaife, S.G.B. Amyes, and H.K. Young. 2000. Sequence analysis of ARI-1, a novel OXA betalactamase, responsible for imipenem resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 44: 196-199.
7. Feizabadi, M.M., B. Fathollahzadeh, M. Taherikalani, M. Rasoolinejad, N. Sadeghifard, M. Aligholi, S. Soroush, and S. Mohammadi-Yegane. 2008. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. isolated from patients at Tehran hospitals. Jpn. J. Infect. Dis. 61:274-278.
8. Fournier, P.E., and H. Richet. 2006. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin. Infect. Dis. 42:692-699.
9. Gur, D., V. Korten, S. Unal, L. Deshpande, and M. Castanheira. 2008. Increasing carbapenem resistance due to the clonal dissemination of oxacillinase (OXA-23 and OXA-58)- producing Acinetobacter baumannii: Report from the Turkish SENTRY Program site. J. Med. Microbiol. 57:1529-1532.
10. Higgins, P.G., L. Poirel, M. Lehmann, P. Nordmann, and H. Seifert. 2009. OXA-143, a novel carbapenem-hydrolyzing class D b-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 53:5035-5038.
11. Katsaragakis, S., H. Markogiannakis, K.G. Toutouzas, P. Drimousis, A. Larentzakis, E.M. Theodoraki, and D. Theodorou. 2008. Acinetobacter baumannii infections in a surgical intensive care unit: Predictors of multi-drug resistance. World J. Surg. 32:1194-1202.
12. Mahillon, J., and M. Chandler. 1998. Insertion sequensce. Microbiol. Mol. Biol. Rev. 62:725-774.
13. Mak, J.K., M.J. Kim, J. Pham, J. Tapsall, and P.A. White. 2009. Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 63:47-54.
14. Mugnier, P.D., L. Poirel, M. Pitout, and P. Nordmann. 2008. Carbapenem resistant and OXA-23-producing Acinetobacter baumannii isolates in the United Arab Emirates. Clin. Microbiol. Infect. 14:879-882.
15. Mugnier, P.D., L. Poirel, T. Naas, and P. Nordmann. 2010. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg. Infect. Dis. 16:35-40.
16. Papa, A., V. Koulourida, and E. Souliou. 2009. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in a newly established Greek hospital. Microb. Drug Resist. 15:257-260.
17. Paton, R., R.S. Miles, J. Hood, and S.G.B. Amyes. 1993. ARI-1: b-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int. J. Antimicrob. Agents 2:81-87.
18. Peleg, A.Y., H. Seifert, and D.L. Paterson. 2008. Acinetobacter baumannii: Emergence of a successful pathogen. Clin. Microbiol. Rev. 21:538-582.
19. Perez, F., A. Hujer, K. Hujer, B. Decker, P. Rather, and R. Bonomo. 2007. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:3471-3484.
20. Poirel, L., S. Marqué, C. Hé ritier, C. Segonds, G. Chabanon, and P. Nordmann. 2005. OXA-58, a novel class D b-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother. 49: 202-208.
21. Poirel, L., and P. Nordmann. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanism and epidemiology. Clin. Microbiol. Infect. 12:826-836.
22. Quale, J., S. Bratu, D. Landman, and R. Heddurshetti. 2003. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin. Infect. Dis. 37:214-220.
23. Quinteira, S., F. Grosso, H. Ramos, and L. Peixe. 2007. Molecular epidemiology of imipenem-resistant Acinetobacter haemolyticus and Acinetobacter baumannii isolates carrying plasmid-mediated OXA-40 from a Portuguese hospital. Antimicrob. Agents Chemother. 51:3465-3466.
24. Rahbar, M., K.M. Monnavar, K.K. Vatan, A. Fadaei-haq, and F. Shakerian. 2008. Carbapenem resistance in gramnegative bacilli isolates in an Iranian 1000-bed Tertiary Hospital. Pak. J. Med. Sci. 24:537-540.
25. Ruiz, M., S. Marti, F. Fernandez-Cuenca, A. Pascual, and J. Vila. 2007. High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clin. Microbiol. Infect. 13:1192-1198.
26. Stoeva, T., P.G. Higgins, E. Savov, R. Markovska, I. Mitov, and H. Seifert. 2009. Nosocomial spread of OXA-23 and OXA-58 beta-lactamase-producing Acinetobacter baumannii in a Bulgarian hospital. J. Antimicrob. Chemother. 63:618-620.
27. Taherikalani, M., B. Fatolahzadeh, M. Emaneini, S. Soroush, and M.M. Feizabadi. 2009. Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals. New Microbiol. 32:265-271.
28. Turton, J.F., M.E. Ward, N. Woodford, M.E. Kaufmann, R. Pike, D.M. Livermore, and T.L. Pitt. 2006. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett. 27:351-353.
29. Turton, J.F., N. Woodford, J. Glover, S. Yarde, M.E. Kaufmann, and T.L. Pitt. 2006. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44:2974-2976.
30. Vahaboglu, H., F. Budak, M. Kasap, G. Gacar, S. Torol, A. Karadenizli, F. Kolayli, and C. Eroglu. 2006. High prevalence of OXA-51-type class b-lactamases among ceftazidimeresistant clinical isolates of Acinetobacter spp.: Co-existence with OXA-58 in multiple centres. J. Antimicrob. Chemother. 58:537-542.
31. Walther-Rasmussen, J., and N. Høiby. 2006. OXA-type carbapenemases. J. Antimicrob. Chemother. 57:373-383.
32. Zhou, H., B.R. Pi, Q. Yang, Y.S. Yu, Y.G. Chen, L.J. Li, and S.S. Zheng. 2007. Dissemination of imipenem-resistant Acinetobacter baumannii strains carrying the ISAba1 blaOXA-23 genes in a Chinese hospital. J. Med. Microbiol. 56:1076-1080.